Hainan Shuangcheng Pharma Stages $94 Million IPO in Shenzhen

Published: Aug 15, 2012

by Richard Daverman, PhD

August 15, 2012 -- Hainan Shuangcheng Pharmaceuticals debuted on the Shenzhen exchange last week, raising 600 million RMB ($94 million) in its IPO offering. Founded in 2000, Hainan Shuangcheng Pharma is a high-tech enterprise specializing in chemosynthetic polypeptide medicines. The offering was priced at 20 RMB, and the company’s shares have moved up to 25.2 RMB in open market trading, a price/earnings ratio of 32. More details....

Stock Symbol: (SHE: 002693)

Back to news